Company Filing History:
Years Active: 2021
Title: The Innovations of Ming-Hong Chien
Introduction: Ming-Hong Chien is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target D-amino acid oxidase (DAAO). His work has implications for treating various diseases and disorders, showcasing his commitment to advancing healthcare solutions.
Latest Patents: Ming-Hong Chien holds a patent for "Inhibitors of D-amino acid oxidase (DAAO) and uses thereof." This patent describes compounds of Formula (I) that inhibit the activity of DAAO. The compounds are intended for treating diseases associated with DAAO, including central nervous system disorders, obesity, diabetes, and hyperlipidemia. Additionally, the patent outlines methods for synthesizing these compounds, highlighting the innovative approaches taken by Chien.
Career Highlights: Throughout his career, Ming-Hong Chien has demonstrated a strong focus on research and development in the pharmaceutical industry. His work at Syneurx International Corp. has positioned him as a key player in the field, contributing to advancements in drug discovery and therapeutic applications.
Collaborations: Ming-Hong Chien has collaborated with esteemed colleagues, including Guochuan Emil Tsai and Ching-Cheng Wang. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion: Ming-Hong Chien's innovative work in the field of DAAO inhibitors exemplifies the impact of dedicated research on healthcare advancements. His contributions continue to pave the way for new therapeutic options, reflecting his commitment to improving patient outcomes.